What You Give Up When You Outsource to a Large CRO — and What to Look For Instead

When selecting a pharmaceutical CRO testing services partner, size is an easy proxy for capability. Large organizations that offer analytical testing — whether as their primary business or as part of a broader service portfolio — have the infrastructure, the service menus, and the regulatory track records to back that perception. But organizational scale also produces operational structures that work well for certain clients and less well for others.

The factors below are not arguments against large organizations as a category. They are the considerations that tend to appear mid-engagement when pharmaceutical and biotech companies reflect on what they wished they had vetted more carefully when selecting a contract testing laboratory.

CROs and Contract Testing Laboratories: A Note on Terminology

“CRO” is widely used as a catch-all for any outsourced research or testing partner, but the two models serve different functions.

  • Contract research organization (CRO) Typically offers broad R&D services — clinical trial management, regulatory affairs, preclinical research, and data management. Many large CROs also include analytical testing within their service catalog.
  • Contract testing laboratory (CTL) Focused specifically on bench-level analytical and microbiology testing as its primary business: method development and validation, lot release, stability studies, extractables and leachables, and similar services.

Key Takeaways

  • Dedicated project management means different things at different organizations — the structure behind the title matters.
  • Method ownership and transfer documentation are often underdiscussed in CRO selection conversations.
  • Account size relative to a CRO’s client base affects how resources and priorities are distributed.
  • Regulatory responsiveness depends on data system quality and internal accountability, not just accreditation status.
  • Depth of experience in a specific testing area is not the same as having that area listed in a capabilities document.

How Account Size Shapes Pharmaceutical CRO Testing Services

Large CROs are structured for volume. That architecture serves large pharmaceutical sponsors well — enterprise clients with multi-year, multi-program agreements tend to receive dedicated resources, named scientific leads, and priority scheduling.

When the Model Works Against You

Mid-size and emerging sponsors occupy a different position. According to Gary Ellsworth, Vice President and Head of North American Alliance Management at IQVIA, mid-size pharmaceutical companies typically need a testing partner “that knows where their resource gaps are and how to prioritize where they most need support based on experience working in similar capacities for other drug developers of similar size, focus and situation.” That need for fit-specific support is where organizational structure becomes a practical variable.

What Shared Service Models Mean in Practice

Smaller accounts at large CROs are typically managed within shared service models. In practice, that can mean:

  • The analyst running your samples is also running samples for multiple other projects
  • Non-standard requests and questions move through a triage system rather than reaching a decision-maker directly
  • Escalations take longer than initial conversations about turnaround time suggested

This is a function of how large organizations are built. It’s worth understanding where your program would sit in that structure before committing.

What to Ask Before You Sign 

→ How many active clients does this team or unit currently support? 

→ What determines resource allocation across accounts — is there a formal tiering system? 

→ Who is the named scientific contact for your project, and what is their current workload? 

→ What is the escalation path if a deadline is at risk?

What ‘Dedicated Project Management’ Covers at an Analytical CRO

Project management is a near-universal CRO offering. The scope of that role varies considerably.

At large organizations, project coordinators often handle scheduling, sample logistics, and report delivery. Scientific questions are routed to a separate technical team. The distinction that matters for complex programs is whether the project manager has direct scientific authority — whether they can answer a method question, authorize a deviation, or make a scheduling call without routing it through additional approvals.

Turnaround Time and Who Controls It

Stated turnaround times reflect capacity under normal conditions. What drives actual turnaround is how priorities are managed across all active projects and how quickly decisions can move through the organization. Three things tend to determine this in practice:

  • The length of the approval chain between your project and the person with authority to act
  • Whether your project manager can resolve deviations independently or must escalate
  • How proactively communication is initiated when something changes

What to Ask Before You Sign 

→ Is a single project manager assigned to this engagement from start to finish, or does coverage rotate? 

→ Does that person have scientific credentials, or is the role primarily administrative? → Can they make method-related decisions directly, or does that require separate approval? 

→ What is the process when a timeline is at risk — who initiates contact, and how quickly?

Method Ownership and What Happens at Transfer

How a contract testing laboratory approaches analytical development and validation — and what documentation and rights you retain — has long-term implications for your program. 

At high-volume organizations, methods are often built on standardized platforms optimized for throughput across common product types. That works efficiently for products that fit the platform. For products with unusual matrices, niche dosage forms, or specific regulatory requirements, development may require adaptations that fall outside the standard workflow.

What a Usable Transfer Package Includes

When a program ends or moves to a different lab, what transfers is only as useful as what was documented. A complete method transfer package should include:

  • The original development rationale and any method optimization history
  • Full validation data across all relevant ICH parameters
  • Notes on instrument sensitivities, matrix effects, or observed variability
  • Qualification data from any receiving site

Labs where method developers and routine analysts are the same people, and where staff turnover is low, tend to produce more complete packages. When those roles are separated or turnover is high, institutional knowledge about how a method behaves may not make it into the documentation.

For programs approaching IND or BLA/NDA submission, confirm upfront what the transfer package will contain, who owns the method documentation, and whether it has supported prior regulatory submissions.

What to Ask Before You Sign 

→ Who owns the methods developed during this engagement — the lab or the sponsor? 

→ Are method developers and routine analysts the same people? 

→ What does a standard transfer package include, and has it been used in a regulatory submission? 

→ What is the average analyst tenure in the relevant department?

Regulatory Responsiveness and Data Integrity

FDA inspections, information requests, and regulatory queries require fast, complete responses. How quickly a CRO can produce supporting documentation depends on the quality of its data systems and how clearly internal accountability is defined.

The documentation typically needed in a regulatory response includes:

  • Raw instrument data and processed results
  • LIMS audit trails and analyst bench records
  • Deviation histories and associated investigations
  • Environmental monitoring and critical utilities records, where applicable

Organizations with distributed data management or long internal approval chains may need several days to compile what a lab with integrated systems and direct accountability can provide in hours.

Beyond Baseline Compliance

cGMP compliance, FDA and DEA registration, and ISO/IEC 17025 accreditation are entry-level requirements. Inspection history is more informative — specifically, whether a lab has received FDA Form 483 observations and how those findings were addressed. A clean inspection record under actual review conditions indicates that quality systems hold up in practice, not just on paper.

For data systems specifically, confirm whether 21 CFR Part 11 compliance is built into integrated platforms or managed through manual processes layered on top of existing tools. The difference matters when audit trail completeness is scrutinized.

What to Ask Before You Sign 

→ When was the most recent FDA inspection, and were there any Form 483 observations? 

→ What LIMS and ELN platforms are in use, and are they fully 21 CFR Part 11 compliant? 

→ How long does it typically take to pull complete study documentation for a regulatory response? 

→ Is audit trail data maintained in a centralized system or distributed across instruments?

Service Breadth vs. Depth When You Outsource Pharmaceutical Testing

A CRO’s capabilities list reflects what the organization can do somewhere across its network. It does not necessarily reflect the concentration of expertise at the specific site or unit that would handle your project.

Testing areas that warrant closer scrutiny when evaluating depth over breadth include:

For any of these areas, the more useful questions are about who would run the work and how much of it they do regularly — not whether the service appears on a capabilities page.

What to Ask Before You Sign

→ How many analysts are dedicated to this testing area, and what are their credentials? 

→ What is the approximate volume of this type of work completed in the last 12 months? 

→ What instrumentation is on-site for this analysis — is anything subcontracted out? 

→ Who would develop and run my methods specifically, and can I speak with them before signing?

Where Mid-Size Contract Testing Laboratories Fit in the Outsourcing Landscape 

Mid-size contract testing laboratories operate at a scale large enough to maintain multi-discipline capabilities, advanced instrumentation, and cGMP-compliant quality systems — and small enough that each client program is a material account. The practical differences for complex or specialized programs often come down to:

  • Direct access to the scientists running your project, not just a relationship coordinator
  • Project managers with scientific backgrounds who can make technical decisions without additional escalation
  • Shorter internal approval chains that reduce friction when timelines or methods need adjustment
  • Staff continuity that preserves method knowledge across the life of a program

For programs that require high-throughput, routine pharmaceutical testing services, large CROs are well-suited. For programs that require more engaged scientific support — or where a large CRO is already handling volume work and a specialist is needed for technically demanding assays — a specialized contract testing laboratory with relevant depth is worth evaluating alongside the larger options.

Questions to Ask Before You Outsource Pharmaceutical Testing

What are the risks of outsourcing critical analytical testing to the wrong lab?

The most consequential risks are regulatory — methods that don’t transfer cleanly, data integrity gaps that surface during an FDA inspection, and turnaround failures that delay IND or NDA submissions. Operational risks include poor communication, lack of scientific accountability, and method documentation that isn’t complete enough to support a regulatory submission or a lab transfer.

What should companies look for when selecting a contract testing laboratory?

Beyond accreditation and regulatory standing, the most important factors are scientific depth in the specific testing areas you need, a project management structure with direct accountability, demonstrated experience with your product type and regulatory pathway, and a quality system that has held up under actual FDA inspection. The “what to ask” sections throughout this post cover each of these in detail.

Can method documentation be transferred if I change labs mid-program?

In most cases, yes — but completeness depends on how the method was documented during development and what the contract specifies about method ownership. Confirming both before engagement starts avoids complications later, particularly for programs approaching regulatory submission.

Is it common to use a large CRO and a specialized lab simultaneously?

Yes. Many pharmaceutical and biotech organizations run routine, high-volume testing through a large CRO while directing technically complex work — extractables and leachables, nitrosamines, biologics, advanced therapeutics — to smaller specialized labs. The two models are complementary rather than mutually exclusive.

What should a quality agreement with a contract testing laboratory cover?

A quality agreement should define responsibilities for cGMP compliance, document control, deviation and OOS investigation procedures, change control notification, audit rights, and data ownership. For analytical testing engagements specifically, it should also address method ownership and what documentation transfers if the relationship ends.

A Contract Analytical Testing Lab Where Every Client Has a Dedicated Project Manager 

BA Sciences is a full-service cGMP-compliant, FDA/DEA registered, ISO/IEC 17025:2017 certified contract testing laboratory with more than 35 years of experience supporting biotech, pharmaceutical, and medical device companies. 

Every client is assigned a dedicated project manager with direct scientific accountability. With facilities in Salem, NH, Framingham, MA, and Research Triangle Park, NC, BA Sciences provides analytical development and validation, microbiology testing, stability and storage, extractables and leachables, nitrosamines testing, biologics testing, and more.

Request a quote and talk to us about your project.

Read More

How to Develop a Great Working Relationship with Your CRO
5 Considerations When Choosing an Analytical Testing Lab
What Is Analytical Testing?

Tell Us About Your Project